Below is the list of current research trials for which we are actively seeking study participants. To find out more about participating in one of the studies listed below, click on Contact Me. You may also contact either Cindy Rutherford or Noemi Mendoza directly at 708-366-9300, they may be able to speak with you immediately or you may leave your contact information on their voicemail (if you leave a message, don't forget to leave your name, phone number, and best time(s) to reach you); they will do their best to respond within one business day of your email or phone contact.
Please don't send us any specific information about your medical history via email; despite our best assurances we don't believe that email is ever 100% confidential.
| | | |
|---|
| Asthma | A 12 week, double-blind, randomized, multi-center, parallel-group study evaluating the efficacy, safety, and patient use of Symbicort Breath Actuated Metered Dose Inhaler 2x 160/4.5 mcg twice daily compared with Symbicort Actuation Counter 2x 160mcg twice daily and budesonide AC pMDI 2x 160mcg twice daily in adult asthmatics | > 18 | No Placebo; Call 708-366-9300 for more information | | Asthma | A Randomized, Double-Blind Study to Evaluate the Efficacy of Tralokinumab in Adults with Uncontrolled, Severe Asthma | 18-75 | Call 708-366-9300 for more information | | COPD | 54 wk. randomized, study of the safety and tolerability of a fixed-dose combination of aclidinium bromide/fomoterol fumarate compared with formoterol fumarate in patients with moderate to severe, stable chronic COPD | > 40 | No Placebo; Call 708-366-9300 | | COPD | A phase 2 double-blind, placebo-controlled study to evaluate the efficacy of MEDI8968 in Cronic Obstructive Pulmonary Disease | >40 | Call 708-366-9300 for more information | | COPD | A Clinical Outcomes Study to compare the effect of Fluticasone Furoate/Vilanterol Inhalation Powder 100/23mcg with placebo on Survival in Subjects with moderate COPD and a history of or at increased risk for cardiovascular disease | > 40 | Call 708-366-9300 for more information; No Placebo Arm | | COPD | Randomized Double-Blind, Pacebo-Controlled Study Evaluating the Efficacy, Safety, and Tolerability of Two Fixed Dose Combinations of Aclidinium Bromide/Formoterol Fumarate Compared With Aclidinium Bromide, Formoterol Fumarate and Placebo for 24 wks. Tx. in Patients with Moderate to Severe, Stable COPD | > 40 | Call 708-366-9300 for more information |
Showing 6 items
|
